Strengthening the foundations of clinical pharmacology​

A review of the MBBS Clinical Pharmacology Curriculum was coordinated by the Education and Training and Clinical Committees. Led by the Deputy Vice President (Clinical) Dr Dagan Lonsdale, this review will ensure the curriculum reflects changes in clinical pharmacology practices and inform and improve patient care over the long term. This work underpins our belief that pharmacology and therapeutics are evolving, and it is our responsibility to define, redefine and advance these disciplines. 

Following the publication of the independent review of Prescribing Safety Assessment, led by Professor Dame Jane Dacre in 2023, the Society has continued to work with the Medical Schools Council to progress the key recommendations. In 2024 we administered 9,700 UK undergraduate sittings, supporting the next generation of medical prescribers build their confidence and enter the medical profession with the skills, knowledge and competence to prescribe safely. 

Over 120 delegates attended our event celebrating 50 years of the British Journal of Clinical Pharmacology at Queen Mary’s University of London, with very positive feedback from attendees. The event brought together past and present members of the editorial board and celebrated the significant contribution the journal has made to the specialty in 50years.  The symposium featured engaging sessions designed to illuminate the trajectory of clinical pharmacology by delving into the historical roots of the BJCP, through the exploration of pivotal moments post-WWII, and navigating contemporary issues and future trends in clinical pharmacology such as global outreach to personalised medicine and clinical drug development.  

The UK Pharmacogenomics and Stratified Medicines Network hosted its 11th Annual Open Meeting at the Royal College of Physicians in London. This flagship event brought together over 120 experts from academia, healthcare, industry, and regulatory bodies to explore the latest developments in pharmacogenetics and stratified medicine. The meeting featured extended networking sessions and an exhibition showcasing innovative work in personalised medicine.  

---

Next: Bringing the pharmacological community together
Previous: Message from the President
Go back to Annual Review 2024